Further evidence for promoting transdermal estrogens in the management of postmenopausal symptoms.
作者信息
Canonico Marianne, Scarabin Pierre-Yves
出版信息
Menopause. 2011 Oct;18(10):1038-9. doi: 10.1097/gme.0b013e31822d6677.
Abstract
摘要
相似文献
1
Further evidence for promoting transdermal estrogens in the management of postmenopausal symptoms.
Menopause. 2011 Oct;18(10):1038-9. doi: 10.1097/gme.0b013e31822d6677.
2
Transdermal and vaginal estradiol for the treatment of menopausal symptoms: the nuts and bolts.
Menopause. 2012 Jun;19(6):602-3. doi: 10.1097/gme.0b013e31824c8a5a.
3
Increased thrombin generation among postmenopausal women using hormone therapy: importance of the route of estrogen administration and progestogens.
Menopause. 2011 Aug;18(8):873-9. doi: 10.1097/gme.0b013e31820eee88.
4
Hormone therapy and hemostasis among postmenopausal women: a review.
Menopause. 2014 Jul;21(7):753-62. doi: 10.1097/GME.0000000000000296.
5
Hormone therapy and risk of venous thromboembolism among postmenopausal women.
Maturitas. 2015 Nov;82(3):304-7. doi: 10.1016/j.maturitas.2015.06.040. Epub 2015 Jul 26.
6
Patch instead of pill: a safer menopausal estrogen?
Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):136-7. doi: 10.1161/ATVBAHA.109.199083.
7
Hormones and venous thromboembolism among postmenopausal women.
Climacteric. 2014 Dec;17 Suppl 2:34-7. doi: 10.3109/13697137.2014.956717. Epub 2014 Sep 16.
8
Hormone therapy and risk of venous thromboembolism among postmenopausal women.
Climacteric. 2009;12 Suppl 1:76-80. doi: 10.1080/13697130903006837.
9
ACOG committee opinion no. 556: Postmenopausal estrogen therapy: route of administration and risk of venous thromboembolism.
Obstet Gynecol. 2013 Apr;121(4):887-890. doi: 10.1097/01.AOG.0000428645.90795.d9.
10
[Hormone therapy and risk for venous thromboembolism in postmenopausal women].
Rev Prat. 2005 Feb 28;55(4):389-92.
本文引用的文献
1
Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy.
Menopause. 2011 Oct;18(10):1052-9. doi: 10.1097/gme.0b013e3182175e5c.
2
Increased thrombin generation among postmenopausal women using hormone therapy: importance of the route of estrogen administration and progestogens.
Menopause. 2011 Aug;18(8):873-9. doi: 10.1097/gme.0b013e31820eee88.
3
Increased thrombin generation is associated with acute ischemic stroke but not with coronary heart disease in the elderly: the Three-City cohort study.
Arterioscler Thromb Vasc Biol. 2011 Jun;31(6):1445-51. doi: 10.1161/ATVBAHA.111.223453. Epub 2011 Mar 31.
4
Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women.
Curr Opin Hematol. 2010 Sep;17(5):457-63. doi: 10.1097/MOH.0b013e32833c07bc.
5
Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study.
BMJ. 2010 Jun 3;340:c2519. doi: 10.1136/bmj.c2519.
6
Hormone replacement therapy and the risk of venous thromboembolism: a population-based study.
J Thromb Haemost. 2010 May;8(5):979-86. doi: 10.1111/j.1538-7836.2010.03839.x. Epub 2010 Mar 4.
7
Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study.
Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):340-5. doi: 10.1161/ATVBAHA.109.196022. Epub 2009 Oct 15.
8
Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.
Menopause. 2008 Jul-Aug;15(4 Pt 1):584-602. doi: 10.1097/gme.0b013e31817b076a.
9
Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis.
BMJ. 2008 May 31;336(7655):1227-31. doi: 10.1136/bmj.39555.441944.BE. Epub 2008 May 20.
10
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.
JAMA. 2007 Apr 4;297(13):1465-77. doi: 10.1001/jama.297.13.1465.
Zotero 插件